Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03793309Phase 1Completed
Phase 1, randomised, open-label trial of vitamin d in immunodeficiency (2 arms), sponsored by Cairo University. Primary endpoint: Percent Change in The Number of T Regulatory Cells at 1 week. Started Jan 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03793309.